CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
Issuer: CureVac / Key word: Study results CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK...
United States Patrick Perez Sarah Fakih Myriam Mendila Corporate Communications Development Program In Collaboration
Source: marketscreener.com